Company / Gross Profit per Share
Bio-Techne Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$4.99
FY2025
5-year range
$4.04 / $12.40
FY2021-FY2025
Trend
+2.3%
vs FY2024
Sector context
#70 of 99
Health Care
What the data says
At $4.99, Bio-Techne's gross profit per share ranks #70 of 99 in the Health Care sector. Gross Profit per Share has fluctuated over the past 10 years, ranging from $4.04 in FY2023 to $12.74 in FY2020.
Based on SEC 10-K filings.
4.99 in FY2025 with a 5-year CAGR of -17.1%.
Improved from $4.04 to $4.99 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -26.2%
- 5-Year CAGR
- -17.1%
- 10-Year CAGR
- -
Sector benchmark
#70 of 99 in Health CareTop 71% of 99This company $4.99 Sector average $13.82
▼
-63.9% below sector average
Key checks
Key Insights
- In FY2025, gross profit per share increased 2.3% year-over-year.
- Ranks #70 out of 99 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2020.
- Lowest gross profit per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.99 | +2.3% |
| FY2024 | $4.88 | +20.9% |
| FY2023 | $4.04 | -67.4% |
| FY2022 | $12.40 | +0.7% |
| FY2021 | $12.31 | -3.3% |
| FY2020 | $12.74 | +1.2% |
| FY2019 | $12.59 | +10.9% |
| FY2018 | $11.36 | +13.0% |
| FY2017 | $10.05 | +11.0% |
| FY2016 | $9.06 | +9.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026